A naturally occurring peptide called PEPITEM could potentially rejuvenate the immune response in older individuals and protect against ‘inflammageing’, which is widely believed to be the root cause of many age-related diseases.

The study, published today in the journal npj Aging, raises the exciting possibility of a protective agent that could dampen age-related inflammation and restore normal immune function in older adults.

PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration) was initially identified at the University of Birmingham in 2015. While the role of the PEPITEM pathway has already been demonstrated in immune-mediated diseases, this is the first data showing that PEPITEM has the potential to increase healthspan in an aging population.

Researchers, led by Drs M...

Researchers developed a novel electrode that effectively suppresses the harmful self-discharge phenomenon in flowless zinc-bromine batteries. The flowless zinc-bromine battery (FLZBB) is a promising alternative to flammable lithium-ion batteries due to its use of non-flammable electrolytes...

Europe’s next big space mission – a telescope that will hunt for Earth-like rocky planets outside of our solar system — is on course to launch at the end of 2026.

PLATO, or PLAnetary Transits and Oscillations of stars, is being built to find nearby potentially habitable worlds around Sun-like stars that we can examine in detail.

The space telescope will blast into orbit on Europe’s new rocket, Ariane-6, which made its maiden flight last week after being developed at a cost of €4billion (£3.4billion).

Dr David Brown, of the University of Warwick, is giving an update on the mission at the Royal Astronomical Society’s National Astronomy Meeting at t...

A team led by UT Southwestern Medical Center researchers has discovered a new way that cells regulate senescence, an irreversible end to cell division. The findings, published in Cell, could one day lead to new interventions for a variety of conditions associated with aging, including neurodegenerative and cardiovascular diseases, diabetes, and cancer, as well as new therapies for a collection of diseases known as ribosomopathies.

“There is great interest in reducing senescence to slow or reverse aging or aging-associated diseases...